Related Experiment Video

Updated: May 12, 2026

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

Remote ischemic preconditioning in hemodialysis: a pilot study

Jongha Park1, Soe Hee Ann, Hyun Chul Chung

  • 1Division of Nephrology, Ulsan University Hospital, University of Ulsan College of Medicine, 290-3 Jeonha-dong, Dong-gu, Ulsan, 682-714, South Korea.

Heart and Vessels
|March 28, 2013
PubMed

Insights

Remote ischemic preconditioning (RIPC) reduced cardiac troponin T levels in hemodialysis patients, indicating a protective effect against heart injury during dialysis. This simple, safe method offers a potential benefit for chronic hemodialysis patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Physiology

Background:

  • Hemodialysis (HD) can induce myocardial ischemia, evidenced by elevated cardiac troponin T (cTnT), even in asymptomatic patients.
  • Remote ischemic preconditioning (RIPC) is known to protect against myocardial ischemia-reperfusion injury.

Purpose of the Study:

  • To investigate the protective effect of RIPC on hemodialysis-induced myocardial injury.
  • To determine if RIPC can reduce cTnT levels in chronic HD patients.

Main Methods:

  • A randomized controlled trial involving chronic HD patients assigned to a control or RIPC group.
  • RIPC involved 3 cycles of 5-minute arm occlusion and 5-minute reperfusion before each HD session for 1 month.
  • The primary outcome was the change in cTnT levels at day 28 from baseline.

Main Results:

  • No significant demographic or baseline laboratory differences between groups (n=17 each).
  • cTnT levels tended to decrease in the RIPC group from day 2 to day 28, unlike the control group.
  • A significant reduction in cTnT change from baseline was observed at day 28 in the RIPC group compared to the control group (P=0.012).

Conclusions:

  • RIPC effectively reduced cTnT release in chronic conventional HD patients.
  • RIPC demonstrates a protective effect against hemodialysis-induced myocardial ischemia.
  • RIPC is a simple, inexpensive, safe, and well-tolerated intervention for HD patients.

More Related Videos

Use of a Hanging-weight System for Isolated Renal Artery Occlusion07:54

Use of a Hanging-weight System for Isolated Renal Artery Occlusion

Published on: July 19, 2011

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells06:23

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells

Published on: November 21, 2025

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...